October 26, 2023
CAMBRIDGE, England -- Qkine, an industry-leading manufacturer of animal-free, highly pure recombinant proteins, is delighted to announce a sales distribution agreement with Thomas Scientific to enable fast and easy purchasing of Qkine growth factors and cytokines for stem cell scientists based in the United States. Thomas Scientific serves as a solutions provider for complex scientific workflows [...]
Beckman Coulter Life Sciences and 10x Genomics Partner to Enable Single Cell Workflow Automation
October 26, 2023
INDIANAPOLIS and PLEASANTON, Calif. – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a new partnership to expand automation solutions for single cell assay workflows. As part of the agreement, 10x Genomics plans to develop [...]
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
October 26, 2023
Partnership covers development of lab-developed and distributable kit-based companion diagnostic tests Combined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion diagnostic solutions based on PCR, digital PCR (using the QIAcuity system), and NGS Future projects may include advanced analysis and accessibility of measurable residual disease (MRD) and homologous [...]
Revvity Debuts Inaugural ESG Report
October 26, 2023
WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY) today unveils its inaugural 2023 Environmental, Social and Governance (ESG) Report. An in-depth overview of the Company’s ESG strategy, initiatives and performance, the report showcases the Company’s deepening commitment to driving more sustainable solutions, along with a culture of transparency, empowerment and inclusivity. “Revvity’s ESG program and goals boldly represent [...]
October 26, 2023
By integrating Labbit LIMS, LinusBio harnesses cutting-edge informatics to optimize its ground-breaking exposome sequencing platform, advancing discovery across various complex health conditions such as Autism in young children. NEW YORK, Oct. 26, 2023 /PRNewswire/ - Semaphore Solutions, an innovative leader in laboratory informatics services and LIMS, is delighted to join forces with LinusBio, a pioneer in precision [...]
STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence
October 26, 2023
Toronto, ON – STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre in downtown Toronto, Ontario. “The opening of our new Toronto base marks a major milestone in STEMCELL’s 30-year history and is a testament to our growing presence in North America,” [...]
OGT and Intelliseq launch NGS reporting and interpretation for all myeloid malignancy panels
October 26, 2023
Oxford, UK – OGT, A Sysmex Group Company and leading global provider of clinical research solutions, and Intelliseq, a genome informatics company, are delighted to announce the release of GeneSpect™ Somatic Reporter for use with OGT’s SureSeq™ portfolio of next generation sequencing (NGS) panels. This advanced analytical reporting solution pairs state-of-the-art variant interpretation and reporting with [...]
908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device
October 25, 2023
BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces today that it has been awarded a total of $10.4 million in purchase orders from the United States Air Force and Air National Guard Fire & Emergency Services Program for its MX908 handheld mass spectrometry device with Aero module. [...]
Cytiva and RoosterBio collaborate to address exosome manufacturing challenges
October 25, 2023
Biotechnology leaders Cytiva and RoosterBio, Inc., are teaming up to develop a purification process to manufacture exosomes in mass quantities. This collaboration brings together the strengths of both companies to solve one of the biggest challenges currently limiting the use of exosomes as therapeutics and as delivery vehicles for gene therapies and other biologics. Exosomes [...]
Vizgen Announces MERSCOPE® Platform Grant Program Winners
October 25, 2023
Grants awarded to researchers with most innovative and impactful proposals in cancer research Aveline Filliol of Memorial Sloan Kettering Cancer Center and Marek Piprek of VIB-KU Leuven Center for Cancer Biology to receive a full Vizgen® Lab Services MERFISH study generated on the MERSCOPE Platform CAMBRIDGE, Mass. -- Vizgen, the life science company dedicated to improving [...]

